Clinical trials and essential hiring will continue, acting director of National Institute of Health says. [View all]
Source: New York Times
Clinical trials at the National Institutes of Health and at organizations it funds may continue, and patients may still travel to trial sites to participate in research, despite the Trump administration's restrictions on travel and communications, the acting director of the N.I.H., Dr. Matthew Memoli, said in an email to staff on Monday.
While Dr. Memoli’s announcement provided some clarification, it left many questions unanswered. Communications staff at the N.I.H. did not pick up the phone or respond to emails requesting additional information.
Dr. Memoli’s note emphasized that critical purchases for needed laboratory supplies and any contracting required “for anything directly related to human safety, human or animal health care, security, biosafety, biosecurity or I.T. security,” could continue.
Likewise, the email said, essential purchases and contracting needed to sustain research experiments that started before to Jan. 20 could be made “so that this work can continue, and we do not lose our investment in these studies,” Dr. Memoli said.
Read more: https://www.nytimes.com/live/2025/01/29/us/trump-federal-freeze-funding-news#nih-trials-research
Trump seems to be restoring activities about which he's received the most pushback.
= new reply since forum marked as read